← Back to headlines
Atara Biotherapeutics Stock Jumps on FDA Cell Therapy Report
Shares of Atara Biotherapeutics surged following reports of a potential U-turn by the FDA regarding its cell therapy.
25 Feb, 18:56 — 25 Feb, 18:56
ℹOnly 1 source covers this story
